Sales & Marketing news

• Judges unveiled for Masters of Marketing Awards

  14-03-2017 18:16
  
  Top marketers from BT, Walt Disney, News UK and Direct Line are among the jury for Marketing Week’s Masters of Marketing Awards.
  The Awards celebrate every aspect of a marketer’s job from strategy through to execution, while also rewarding excellence in key vertical sectors and in tackling some of the biggest issues and challenges brands face.
  Winners will be decided by a jury of senior marketers. Those taking part this year include BT’s chief brand officer Zaid Al-Qassab, Walt
  
  Read more

• The FA tackles ‘old-fashioned stereotypes’ around who can play football

  14-03-2017 18:03
  
  The Football Association (FA) is increasing its focus on women through its marketing activity as it admits there are still “old-fashioned stereotypes” to tackle.
  The company unveiled its new brand purpose ‘For All’ yesterday (13 March), alongside two short films and a series of case studies to create greater awareness of The FA’s role.
  The first film stars England Lioness defender, Casey Stoney. It documents her journey from being the only girl in her youth team to
  
  Read more

• Mark Ritson: Believe it or not, Ivanka’s brand benefits from Trump’s presidency

  14-03-2017 17:27
  
  Ten years ago a young American entrepreneur and business school graduate took a gamble. Frustrated with jewellers who appeared to exclusively target male customers when promoting female jewellery, she set out to create a collection of rings, necklaces and bracelets that were inspired by and created for successful modern women who choose their own jewellery.
  A year later and the success of the initial business led her to extend her brand into women’s footwear, then accessories and finally f
  
  Read more

• Aviva UK CEO: Marketing shouldn’t be the only function responsible for customers

  14-03-2017 16:07
  
  Andy Briggs has just been promoted from CEO of Aviva’s life insurance division to head its combined life, general and health insurance businesses.
  He has over 25 years’ experience working in finance and insurance having previously been CEO at Scottish Widows, the life business of Lloyds Banking Group and the Prudential Group’s Retirement Income business.
  While he works closely with marketing, he has never been a marketer. Here he shares his views of the discipline.
  Markete
  
  Read more

• Advertisement

• Channel 4 CEO David Abraham to step down after seven years

  14-03-2017 15:54
  
  UPDATED 15:23: Channel 4 has now confirmed the news. Abraham intends to step down from his role by the end of 2017 in order to develop personal plans to launch a media enterprise in 2018. David will remain in role until a new chief executive has been appointed and is in post.
  Channel 4 CEO and former marketer David Abraham is stepping down as chief executive after seven years.
  The announcement was made in a tweet by the Channel 4 press office this afternoon (14 March), but was deleted after 10 m
  
  Read more

• Channel 4 CEO David Abraham set to step down after seven years

  14-03-2017 15:54
  
  UPDATED 15:23: Channel 4 has now confirmed the news. Abraham intends to step down from his role by the end of 2017 in order to develop personal plans to launch a media enterprise in 2018. David will remain in role until a new chief executive has been appointed and is in post.
  Channel 4 CEO and former marketer David Abraham is stepping down as chief executive after seven years.
  The announcement was made in a tweet by the Channel 4 press office this afternoon (14 March), but was deleted after 10 m
  
  Read more

• Natural gas plunges as the blizzard misses NYC

  14-03-2017 15:19 via feedproxy.google.com
  
  Natural gas is down 2.5% at $2.966 per British thermal unit after winter storm Stella turned out not to be as bad as initially feared. The storm was expected to dump up to two feet of snow on New York City, but has shifted inward, meaning customers may not use as much as natural gas as initially expected. 
  Natural gas prices have made a comeback after a rough start to the year. They tumbled to a low of about $2.65 per million British thermal unit in late February, before
  
  Read more

• Here are the biggest winners and losers from 'Trumpcare'

  14-03-2017 15:09 via feedproxy.google.com
  
  Not everyone will gain the same benefits from the American Health Care Act, the GOP replacement for the Affordable Care Act, also known as Obamacare.
  Due to differences in the tax credit structure under the AHCA, older and poorer people will receive less assistance to gain access to care, according to analysis done by nonpartisan groups. Additionally, not every state will benefit in the same way.
  The Kaiser Family Foundation, a non-partisan health policy think tank, broke down the AHCA's ta
  
  Read more

• Advertisement

• Wall Street's bond traders are crushing it

  14-03-2017 14:53 via feedproxy.google.com
  
  Wall Street's most important business is having a bumper start to the year. 
  Fixed income, currency and commodities (FICC) revenues are set to increase 34% in the first quarter from a year ago thanks to rising trading volumes, according to JPMorgan analyst Kian Abouhossen. 
  Abouhossen wrote in a note to clients that credit trading businesses have likely done well as a result of increased trading and so-called inventory gains. These are where the positions on a bank's books increas
  
  Read more

• And yes, Valeant's stock is getting hammered (VRX)

  14-03-2017 14:53 via feedproxy.google.com
  
  Valeant's stock is down around 9%, sliding on the news that investor Bill Ackman's hedge fund, Pershing Square, is unloading its entire stake in the company.
  This ends a three-year involvement with the company for Ackman. During that time, Valeant's stock price fell from a high of about $279 in the summer of 2015, to where it sits under $11 today.
  The company became the subject of several federal investigations, including one involving a secret pharmacy that it used to operate which is now be ac
  
  Read more

• KRUGMAN: 'Trumpcare' is 'stupid and cruel'

  14-03-2017 14:46 via feedproxy.google.com
  
  Paul Krugman on Tuesday raged against the American Health Care Act, the GOP's replacement for the Affordable Care Act, arguing it would be potentially devastating for Trump voters.
  The Nobel laureate and New York Times economic columnist said in a series of tweets that the AHCA, which has become alternately known as Ryancare (for House Speaker Paul Ryan) or Trumpcare (for President Donald Trump), makes healthcare in the individual marketplace more expensive for older Ame
  
  Read more

• 10 things in tech you need to know today (SNAP, AAPL, YHOO, FB, NTDOY)

  14-03-2017 14:42 via feedproxy.google.com
  
  Good morning! Here is the tech news you need to know this Tuesday.
  1. Marissa Mayer won't be the CEO of Yahoo's remaining business after the Verizon deal closes. The remaining business will be called Altaba.
  2. Snapchat has started hiring people in Germany. The photo-sharing company is looking to set up an office in Berlin or Hamburg.
  3. Security startup Okta has filed for its long-awaited IPO. The $1.2 billion company said that it plans to list shares on the Nasdaq exchange under the ticker "OK
  
  Read more

• ROBERT SHILLER: 'This market is way overpriced'

  14-03-2017 14:40 via feedproxy.google.com
  
  Even Robert Shiller is worried about stock market valuations. 
  The author of "Irrational Exuberance," a seminal book on volatility and behavioral economics that was released right as the dot-com bubble collapsed, is having flashbacks of that era.  
  "The market is way overpriced," Shiller said, according to Bloomberg's Jason Clenfield and Adam Haigh. 
  That is accurate by many measures, including Shiller's price-to-earnings ratio, which measures a stock's pr
  
  Read more

• Valeant's collapse — from Clinton's tweet to Ackman's exit (VRX)

  14-03-2017 14:34 via feedproxy.google.com
  
  Bill Ackman has officially quit Valeant Pharmaceuticals.
  The founder of the hedge fund Pershing Square on Monday sold his investment in the company and announced his plan to step down from the board. Valeant's shares were down 9% Tuesday morning.
  Once a stock market darling, Valeant has been falling since September 2015 after the company began to face scrutiny over its pricing strategy and its use of a secret specialty pharmacy called Philidor. When Philidor's existence — which had been ke
  
  Read more

• Agencies shouldn’t reinvent the (revenue) wheel

  14-03-2017 13:48
  
  I am getting tired of the whole discussion around the demise of revenue for agencies; the cruise ship versus the speed boat metaphor. What do they even mean? I can understand that a speed boat is able to pivot quicker than a cruise ship but that is because it needs to.If someone on the speed boat needs to turn around and go in a different direction, they will. Not everyone in a cruise ship needs to pivot. Send the key people off in a lifeboat or up in a helicopter for a better view. Don’t
  
  Read more

• It's time to start paying attention to one of the Fed's most controversial charts

  14-03-2017 13:39 via feedproxy.google.com
  
  The Federal Reserve has been infamously overoptimistic about the US economy in recent years, prompting them to frequently revise down their forecasts for economic growth as the year progresses.
  Yet Wall Street will let bygones be bygones this week as the Fed looks set to raise interest rates by another quarter point. That’s because, with the widely-telegraphed rate increase all but baked into expectations, the market’s attention is now turning to the projected path of interest rates
  
  Read more

• Oil tumbles after Saudi Arabia says it increased production

  14-03-2017 13:18 via feedproxy.google.com
  
  Oil has tumbled after Saudi Arabia says it increased production.
  WTI crude, the US benchmark, is down by 0.9% at $47.99 per barrel as of 8:01 a.m. ET. This is the lowest level since late November. Meanwhile, Brent crude oil, the international benchmark, is down by 0.5% at $51.08 per barrel. Again, this is the lowest level since late November.Oil's tumble follows the release of a monthly report by OPEC, which shows that Saudi Arabia increased production in February back above the level of 10
  
  Read more

• Thomas Barta: Being late makes marketers look like overwhelmed leaders

  14-03-2017 13:16
  
  It was one of those baffling days. I was giving a closing keynote speech at a conference, but the event ran late and my slot was pushed back by an hour. The following leadership dinner talk started late too, because the marketing team hadn’t left the office on time.
  There is probably a reason why no language knows the term ‘punctual like a marketer’. But why are marketers always late? Is it the system? The people? And, for marketers, does being late actually matter? Let’s
  
  Read more

• Valeant's downfall — illustrated by its stock chart (VRX)

  14-03-2017 13:13 via feedproxy.google.com
  
  Bill Ackman has officially quit Valeant Pharmaceuticals.
  The founder of the hedge fund Pershing Square on Monday sold his investment in the company and announced his plan to step down from the board. Valeant's shares fell by as much as 10% after-hour on Monday.
  Once a stock market darling, Valeant has been falling since September 2015 after the company began to face scrutiny over its pricing strategy and its use of a secret specialty pharmacy called Philidor. When Philidor's existence — wh
  
  Read more

• The dollar drifts as the Fed gears up for a rate hke

  14-03-2017 12:44 via feedproxy.google.com
  
  The dollar is hovering as the Federal Reserve gets ready for its two-day meeting.
  The US dollar index is up by 0.2% at 101.58 as of 7:26 a.m. ET.
  On Tuesday, the Federal Reserve will begin its two-day meeting. Markets have priced in a 100% probability of a 25 basis point rate hike, according to Bloomberg World Interest Rate Probability data.
  Traders will be keeping their eyes on the Fed's dot plot.
  Separately, regarding US economic data, PPI will be released at 8:30 a.m. ET.
  As for the
  
  Read more

• 10 things you need to know today (SPY, SPX, QQQ, DIA, YHOO, VZ, VRX)

  14-03-2017 11:55 via feedproxy.google.com
  
  Here is what you need to know.
  The CBO's findings on 'Trumpcare' are out. The Congressional Budget Office says the House GOP plan to replace Obamacare would shrink the federal budget deficit by more than $300 billion over the next decade and cause as many as 24 million people to lose their health insurance.
  The Fed begins a 2-day meeting. Markets are pricing in a 100% probability of a 25-basis-point interest-rate hike by the US Federal Reserve when the meeting concludes Wednesday, according to B
  
  Read more

• 10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA, YHOO, VZ, VRX)

  14-03-2017 11:55 via feedproxy.google.com
  
  Here is what you need to know.
  The CBO's findings on 'Trumpcare' are out. The Congressional Budget Office says the House GOP plan to replace Obamacare would shrink the federal budget deficit by more than $300 billion over the next decade and cause as many as 24 million people to lose their health insurance.
  The Fed begins a 2-day meeting. Markets are pricing in a 100% probability of a 25-basis-point interest-rate hike by the US Federal Reserve when the meeting concludes Wednesday, according to B
  
  Read more

• Positive mood boosts digital advertising

  14-03-2017 08:00
  LONDON/NEW YORK: Advertisers able to reach consumers when they're in the right mood could increase the impact of digital advertising by as much as 40%, according to new research.Yahoo's Receptivity of Emotions study was based on...
  
  Read more

• The collapse of Valeant, as told by its stock chart (VRX)

  14-03-2017 01:29 via feedproxy.google.com
  
  Bill Ackman has officially quit Valeant Pharmaceuticals. 
  The founder of hedge fund Pershing Square on Monday sold his investment in the company and will step down from the board. Valeant's shares fell as much as 10% after-hours. 
  The former stock market darling's stock has been falling consistently since September 2015 after the company began to face scrutiny over its pricing strategy, as well as its ties to a specialty pharmacy called Philidor. Its stock is down 95% si
  
  Read more

• Woolworths reveals data-driven loyalty rethink

  14-03-2017 01:00
  SYDNEY: When changesto grocery retailer Woolworths' loyalty programme were met with public pushback, the company used the lesson to build a data-driven, more personalised approach, a senior executive at the company has revealed.Ingrid Maes,...
  
  Read more

• PepsiCo champions in-house content

  14-03-2017 01:00
  ORLANDO, FL: PepsiCo, the FMCG group, believes that ramping up its in-house creative capabilities has provided clear advantages in terms of enhanced speed and efficiency, as well as delivering a high standard of marketing output.Ellen Healy,...
  
  Read more

• New effectiveness claim for Facebook

  14-03-2017 01:00
  NEEDHAM, MA: Brands can gain a useful boost to digital conversion rates by understanding the value of their Facebook investment in relation to other digital channels, new research has shown.Visual IQ, a provider of marketing intelligence software,...
  
  Read more

• Asian millennials face tough future

  14-03-2017 01:00
  HONG KONG: Asia's millennials face a financially uncertain future as, sandwiched betweenlooking after ageing parents and bringing up their own children, many are failing to provide for their own retirement.The findings emerged from the Manulife...
  
  Read more

• AI media buy boosts ROI

  14-03-2017 01:00
  MODENA: Media agencies already under pressure face a new threat as Cosabella, an Italian lingerie firm, has reported significant increases in ROI following its decision to hand over its media-buying activities to artificial intelligence.Courtney...
  
  Read more

• Advertisers need to 'get literate' on digital

  14-03-2017 01:00
  LONDON: Digital advertising is under the microscope as never before, with Google and Facebook facing criticism from all quarters on their record on transparency and the industry struggling to reach a consensus on the best way forward.Last week,...
  
  Read more

• Bill Ackman pinpointed the moment he should've sold out of Valeant — and he's wrong

  14-03-2017 00:31 via feedproxy.google.com
  
  Bill Ackman has sold out of one of his most controversial investments, Valeant Pharmaceuticals, after three years of involvement with the company.
  During that time, Valeant's stock fell from a high of about $257 to where it sits now, just under $11.
  One might call it a teachable moment, in which hard, honest self-reflection is required.
  For his part, Ackman told CNBC's Scott Wapner that he should've sold the stock 18 months ago, when the revelation of a secret pharmacy within Valeant combined w
  
  Read more

Follow @sales_mrktinguk on Twitter!